Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nattokinase Atherothrombotic Prevention Study

NCT02080520 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02080520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02080520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nattokinase Atherothrombotic Prevention Study
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2014
Completion date
July 31, 2019
Enrollment
265 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of cognitive decline, prevention of subclinical atherosclerosis progression